Non-segmental Vitiligo
📧 Sign up to get email alerts when something new happens for Non-segmental Vitiligo.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo [Phase 2]
A Phase 2 clinical trial evaluating LY4005130 in adults with non-segmental vitiligo is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo [Phase 2]
A Phase II clinical trial evaluating the efficacy and safety of VC005 tablets for non-segmental vitiligo is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China
A completed cross-sectional study sponsored by AbbVie assessing the real-world burden of non-segmental vitiligo in China.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV) [Phase 2]
An open-label, single-center Phase 2 study is evaluating roflumilast foam 0.3% in pediatric patients with non-segmental vitiligo and is curr…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: ICP-332 in Subjects With Non-segmental Vitiligo [Phase 2, Phase 3]
A clinical trial update indicates ICP-332 is being studied for non-segmental vitiligo in Phase 2 and Phase 3 with recruitment ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo [Phase 2]
Phase 2 trial evaluating adverse events and changes in disease activity with oral Upadacitinib in adults with non-segmental vitiligo; the st…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo [Phase 3]
Phase 3 trial evaluating topical methotrexate for repigmentation in active non-segmental vitiligo has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation [Phase 4]
Phase 4 trial evaluating latanoprost plus NB-UVB versus each alone for non-segmental vitiligo, with clinical and laboratory evaluation.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) [Phase 3]
Phase 3 trial results for topical ruxolitinib (Opzelura) in non-segmental vitiligo have been posted following completion of TRuE-V1.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating atorvastatin calcium salt and simvastatin-acid sodium salt for repigmentation in active non-segmental vi…
-
CLINICAL_TRIALS other · 2011-06-21Clinical Trial Update: Punchgrafting Techniques for Vitiligo [Phase 4]
Phase 4 clinical trial update on punchgrafting techniques for vitiligo; conditions listed include Non-segmental Vitiligo, Segmental Vitiligo…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo [Phase 4]
Phase 4 trial evaluating whether adding topical fluticasone propionate 0.05% cream to NB-UVB phototherapy improves outcomes in active non-se…